Evaluation strategies for measuring pneumococcal conjugate vaccine impact in low-resource settings

References

• Wahl B, O’Brien KL, Greenbaum A, et al. Burden of Streptococcus pneumoniae and Haemophilus influenzae type b disease in children in the era of conjugate vaccines: global, regional, and national estimates for 2000-15. Lancet Glob Health. 2018;6(7):e744–e57.
   PubMed Web of Science ®Google Scholar
• International Vaccine Access Center JHUBSoPH. The Evidence Base for Pneumococcal Conjugate Vaccines (PCVs): data for decision-making around PCV use in childhood. 2017 [cited 2019 Jul 15]. Available from: https://www.jhsph.edu/ivac/resources/the-evidence-base-for-pcvs/
   Google Scholar
• Johnson HL, Deloria-Knoll M, Levine OS, et al. Systematic evaluation of serotypes causing invasive pneumococcal disease among children under five: the pneumococcal global serotype project. PLoS Med. 2010;7(10). DOI:10.1371/journal.pmed.1000348
   PubMed Web of Science ®Google Scholar
• World Health Organization. Measuring impact of Streptococcus pneumoniae and Haemophilus influenzae type b conjugate vaccination. 2012. [cited 202 Sep 14]. Available from:https://apps.who.int/iris/handle/10665/75835
   Google Scholar
• GAVI The Vaccine Alliance. [cited 2020 Juk 15]. Available from: http://www.gavi.org/library/news/press-releases/2013/lao-first-south-east-asian-nation-to-introduce-pneumococcal-and-cervical-cancer-vaccines-with-gavi-support/
   Google Scholar
• World Health Organization. Revised WHO classification and treatment of childhood pneumonia at health facilities. 2014. [cited 2020 Nov 17]. Available from: https://apps.who.int/iris/bitstream/handle/10665/137319/9789241507813_eng.pdf.
   Google Scholar
• World Health Organization. Integrated Management of Childhood Illness: chart booklet. 2014. [cited 2020 Nov 17]. Available from:https://www.who.int/publications/i/item/9789241506823
   Google Scholar
• Weaver R, Nguyen CD, Chan J, et al. The effectiveness of the 13-valent pneumococcal conjugate vaccine against hypoxic pneumonia in children in Lao People’s Democratic Republic: an observational hospital-based test-negative study. Lancet Regional Health Western Pacific. 2020;2:100014.
   Google Scholar
• Nguyen VH, Dubot-Peres A, Russell FM, et al. Acute respiratory infections in hospitalized children in Vientiane, Lao PDR - the importance of Respiratory Syncytial Virus. Sci Rep. 2017;7(1):9318.
   PubMedGoogle Scholar
• Loughlin AM, Hsu K, Silverio AL, et al. Direct and indirect effects of PCV13 on nasopharyngeal carriage of PCV13 unique pneumococcal serotypes in Massachusetts’ children. Pediatr Infect Dis J. 2014;33(5):504–510.
   PubMed Web of Science ®Google Scholar
• Chan J, Nguyen CD, Lai JYR, et al. Determining the pneumococcal conjugate vaccine coverage required for indirect protection against vaccine-type pneumococcal carriage in low and middle-income countries: a protocol for a prospective observational study. BMJ Open. 2018;8(5):e021512.
   PubMed Web of Science ®Google Scholar
• Anderson M, Luangxay K, Sisouk K, et al. Epidemiology of bacteremia in young hospitalized infants in Vientiane, Laos, 2000-2011. J Trop Pediatr. 2014;60(1):10–16.
   PubMed Web of Science ®Google Scholar
• Miller AK, Ghionea S, Vongsouvath M, et al. A Robust Incubator to Improve Access to Microbiological Culture in Low Resource Environments. J Med Devices. 2019;13(1):011007.
   Google Scholar
• World Health Organization. Vaccine Preventable Diseases Surveillance Standards: pneumococcus. 2018. [cited 2021 Aug 10]. Available from: https://www.who.int/publications/m/item/vaccine-preventable-diseases-surveillance-standards-pneumococcus
   Google Scholar
• Habib M, Porter BD, Satzke C. Capsular serotyping of Streptococcus pneumoniae using the Quellung reaction. J Vis Exp. 2014 Feb 24; (84):e51208.
   PubMed Web of Science ®Google Scholar
• Porter BD, Ortika BD, Satzke C. Capsular Serotyping of Streptococcus pneumoniae by latex agglutination. J Vis Exp. 2014 Sep 25;(91):51747.
   PubMed Web of Science ®Google Scholar
• Chan J, Lai JYR, Nguyen CD, et al. Indirect effects of 13-valent pneumococcal conjugate vaccine on pneumococcal carriage in children hospitalised with acute respiratory infection despite heterogeneous vaccine coverage: an observational study in Lao People’s Democratic Republic. BMJ Glob Health. 2021;6(6):e005187.
   PubMed Web of Science ®Google Scholar
• Satzke C, Dunne EM, Porter BD, et al. The PneuCarriage Project: a Multi-Centre Comparative Study to Identify the Best Serotyping Methods for Examining Pneumococcal Carriage in Vaccine Evaluation Studies. PLoS Med. 2015;12(11):e1001903.
   PubMed Web of Science ®Google Scholar
• Satzke C, Dunne EM, Choummanivong M, et al. Pneumococcal carriage in vaccine-eligible children and unvaccinated infants in Lao PDR two years following the introduction of the 13-valent pneumococcal conjugate vaccine. Vaccine. 2019;37(2):296–305.
   PubMed Web of Science ®Google Scholar
• Gatera M, Uwimana J, Manzi E, et al. Use of administrative records to assess pneumococcal conjugate vaccine impact on pediatric meningitis and pneumonia hospitalizations in Rwanda. Vaccine. 2016;34(44):5321–5328.
   PubMed Web of Science ®Google Scholar
• Sgambatti S, Minamisava R, Afonso ET, et al. Appropriateness of administrative data for vaccine impact evaluation: the case of pneumonia hospitalizations and pneumococcal vaccine in Brazil. Epidemiol Infect. 2015;143(2):334–342.
   PubMed Web of Science ®Google Scholar
• Reyburn R, Nand D, Nguyen C, et al. Validation of administrative data to estimate vaccine impact: audit of the Fiji hospital admissions electronic database, 2007-2011 & 2014-2015. Vaccine. 2017;35(47):6416–6421.
   PubMed Web of Science ®Google Scholar
• Reyburn R, Tuivaga E, Nguyen CD, et al. Effect of ten-valent pneumococcal conjugate vaccine introduction on pneumonia hospital admissions in Fiji: a time-series analysis. Lancet Glob Health. 2021;9(1):e91–e8.
   PubMed Web of Science ®Google Scholar
• Russell FM, Reyburn R, Chan J, et al. Impact of the change in WHO’s severe pneumonia case definition on hospitalized pneumonia epidemiology: case studies from six countries. Bull World Health Organ. 2019;97(6):386–393.
   PubMed Web of Science ®Google Scholar
• Weinberger DM, Warren JL. Estimating the power to detect a change caused by a vaccine from time series data. Gates Open Res. 2020;4:27.
   PubMedGoogle Scholar
• Auranen K, Rinta-Kokko H, Goldblatt D, et al. Design questions for Streptococcus pneumoniae vaccine trials with a colonisation endpoint. Vaccine. 2013;32(1):159–164.
   PubMed Web of Science ®Google Scholar
• Verani JR, Baqui AH, Broome CV, et al. Case-control vaccine effectiveness studies: preparation, design, and enrollment of cases and controls. Vaccine. 2017;35(25):3295–3302.
   PubMed Web of Science ®Google Scholar
• Verani JR, Baqui AH, Broome CV, et al. Case-control vaccine effectiveness studies: data collection, analysis and reporting results. Vaccine. 2017;35(25):3303–3308.
   PubMed Web of Science ®Google Scholar
• de Oliveira LH, Shioda K, Valenzuela MT, et al. Declines in pneumonia mortality following the introduction of pneumococcal conjugate vaccines in Latin American and Caribbean countries. Clin Infect Dis. 2021Jul 15;73(2):306-313.
   Google Scholar
• Moore CE, Sengduangphachanh A, Thaojaikong T, et al. Enhanced determination of Streptococcus pneumoniae serotypes associated with invasive disease in Laos by using a real-time polymerase chain reaction serotyping assay with cerebrospinal fluid. Am J Trop Med Hyg. 2010;83(3):451–457.
   PubMed Web of Science ®Google Scholar
• Khennavong M, Davone V, Vongsouvath M, et al. Urine antibiotic activity in patients presenting to hospitals in Laos: implications for worsening antibiotic resistance. Am J Trop Med Hyg. 2011;85(2):295–302.
   PubMed Web of Science ®Google Scholar
• Levine OS, Cherian T, Hajjeh R, et al. Progress and future challenges in coordinated surveillance and detection of pneumococcal and Hib disease in developing countries. Clin Infect Dis. 2009;48(Suppl 2):S33–6.
   PubMedGoogle Scholar
• Turner P, Leab P, Ly S, et al. Impact of 13-Valent Pneumococcal Conjugate Vaccine on Colonisation and Invasive Disease in Cambodian Children. Clin Infect Dis. 2019;70(8):1580–1588.
   Web of Science ®Google Scholar
• von Mollendorf C, Dunne EM, La Vincente S, et al. Pneumococcal carriage in children in Ulaanbaatar, Mongolia before and one year after the introduction of the 13-valent pneumococcal conjugate vaccine. Vaccine. 2019;37(30):4068–4075.
   PubMed Web of Science ®Google Scholar
• Loo JD, Conklin L, Fleming-Dutra KE, et al. Systematic review of the indirect effect of pneumococcal conjugate vaccine dosing schedules on pneumococcal disease and colonization. Pediatr Infect Dis J. 2014;33(Suppl 2):S161–71.
   PubMed Web of Science ®Google Scholar
• Flasche S, Ojal J, Le Polain De Waroux O, et al. Assessing the efficiency of catch-up campaigns for the introduction of pneumococcal conjugate vaccine: a modelling study based on data from PCV10 introduction in Kilifi, Kenya. BMC Med. 2017;15(1):113.
   PubMed Web of Science ®Google Scholar
• Weinberger DM, Malley R, Lipsitch M. Serotype replacement in disease after pneumococcal vaccination. Lancet. 2011;378(9807):1962–1973.
   PubMed Web of Science ®Google Scholar